We are pleased to congratulate CEO Martin Stenfeldt. COO Rune Wiik Kristensen and the full Medtrace Pharma A/S team with this successful transaction.

The proceeds allow the Company to finance clinical studies in the US while at the same time scaling their European business.

You can find the Børsen article here